Robert Dood, MD MSCE is a gynecologic oncologist and assistant professor at the University of Utah School of Medicine and the Huntsman Cancer Institute. He specializes in the treatment of gynecologic pre-cancers and cancers of the ovary, uterus and endometrium, cervix, vulva, and vagina. His interests include screening and managing high risk and hereditary cancer populations including those with BRCA mutations and Lynch/HNPCC syndromes. He has a passion for fertility-sparing approaches in young women with cancer, pre-cancer, and hereditary syndromes, with special skills in hormonal approaches to endometrial cancer, uterus-sparing surgery for cervix cancer (trachelectomy), and sentinel lymph node evaluation of cervix and uterine cancers. His surgical expertise includes personalized approaches to cancer care, and minimally invasive approaches including both laparoscopic and robotic technologies.
His research interests include implementing enhanced recovery after surgery (ERAS) protocols, optimizing clinical and surgical outcomes, efficient survivorship models, with methods in implementation science and big data.
After completing his Bachelor of Science (BS) degree in Biochemistry from the University of Michigan with High Distinction, he attended the Perelman School of Medicine at the University of Pennsylvania where he received his Medical Doctorate (MD) and Master of Science in Clinical Epidemiology (MSCE) degrees. He completed his residency in Obstetrics and Gynecology at the Hospital of the University of Pennsylvania, and his research and clinical fellowship in Gynecologic Oncology at the University of Texas MD Anderson Cancer Center.
